Bruce N. Jacobs

Chief Financial Officer, Kymera Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$10.0M

Companies

Latest trade

Jun 30, 2026

Companies

Kymera Therapeutics, Inc.Chief Financial Officer −$10.0M

Trades

KYMR Sold 77,109 shares at $114.97 · planned $8.9M Jun 30

KYMR Sold 4,895 shares at $85.30 $0.4M Mar 4

KYMR Sold 7,576 shares at $88.93 $0.7M Mar 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.